Authors:
Damberg, M
Eller, M
Tonissaar, M
Oreland, L
Harro, J
Citation: M. Damberg et al., Levels of transcription factors AP-2 alpha and AP-2 beta in the brainstem are correlated to monoamine turnover in the rat forebrain, NEUROSCI L, 313(1-2), 2001, pp. 102-104
Authors:
Harro, M
Eensoo, D
Kiive, E
Merenakk, L
Alep, J
Oreland, L
Harro, J
Citation: M. Harro et al., Platelet monoamine oxidase in healthy 9-and 15-years old children: The effect of gender, smoking and puberty, PROG NEUR-P, 25(8), 2001, pp. 1497-1511
Citation: J. Harro et al., The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat, NEUROPEPTID, 35(2), 2001, pp. 100-109
Authors:
Harro, J
Tonissaar, M
Eller, M
Kask, A
Oreland, L
Citation: J. Harro et al., Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry, BRAIN RES, 899(1-2), 2001, pp. 227-239
Authors:
Harro, J
Merikula, A
Lepiku, M
Modiri, AR
Rinken, A
Oreland, L
Citation: J. Harro et al., Lesioning of Locus coeruleus projections by DSP-4 neurotoxin treatment: Effect on amphetamine-induced hyperlocomotion and dopamine D-2 receptor binding in rats, PHARM TOX, 86(5), 2000, pp. 197-202
Authors:
Prince, JA
Harro, J
Blennow, K
Gottfries, CG
Oreland, L
Citation: Ja. Prince et al., Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics, NEUROPSYCH, 22(3), 2000, pp. 284-292
Citation: A. Kask et al., Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the rat, NEUROPEPTID, 34(1), 2000, pp. 58-61
Citation: A. Kask et J. Harro, Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide YY1 receptor antagonist BIBO 3304, NEUROPHARM, 39(7), 2000, pp. 1292-1302
Authors:
Kask, A
Schioth, HB
Harro, J
Wikberg, JES
Rago, L
Citation: A. Kask et al., Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide YY1 receptor selective antagonists, CAN J PHYSL, 78(2), 2000, pp. 143-149
Authors:
Harro, J
Haidkind, R
Harro, M
Modiri, AR
Gillberg, PG
Pahkla, R
Matto, V
Oreland, L
Citation: J. Harro et al., Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment, EUR NEUROPS, 10(1), 1999, pp. 5-16
Authors:
Harro, J
Rimm, H
Harro, M
Grauberg, M
Karelson, K
Viru, AM
Citation: J. Harro et al., Association of depressiveness with blunted growth hormone response to maximal physical exercise in young healthy men, PSYCHONEURO, 24(5), 1999, pp. 505-517
Authors:
Harro, J
Pahkla, R
Modiri, AR
Harro, M
Kask, A
Oreland, L
Citation: J. Harro et al., Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and beta-adrenoceptor binding in the rat, J NEURAL TR, 106(7-8), 1999, pp. 619-629
Citation: A. Kask et al., Neuropeptide YY1 receptor antagonist BIBP3226 produces conditioned place aversion in rats, PROG NEUR-P, 23(4), 1999, pp. 705-711